The serious shortage protocol (SSP) for the 10mg tablets of fluoxetine has been extended again, the Department of Health and Social Care (DHSC) has said.
The SSP is now due to expire on 13 May 2022, after previously being expected to expire on 11 February.
Related Article: Drug price concessions hit record high for third consecutive month
The 10mg formula of fluoxetine has been in and out of the SSP list for three years.
Other formulations of the antidepressant have been placed under SSP since the mechanism, which aimed to mitigate the impact of medicine drug shortages, was introduced in 2019.
Related Article: Exclusive: CPE pushes for new service caps to avoid ‘over commissioning’ draining the contract sum
However, the 10mg tablets are the only ones that have remained under the mechanism after the SSP for the 30mg capsules was lifted in June last year.
Under the protocol, pharmacists can supply an alternative of a 10mg fluoxetine capsule instead of the tablet formulation.
In the protocol documents, the DHSC has said: 'Pharmacists are not able to deviate from the recommendations on what to supply to patients as outlined in the SSP for fluoxetine 10mg tablets. However, if pharmacists think that an alternative product not listed in the SSP would be suitable for the
patient, they should either contact the prescriber to discuss this (with the patient’s consent) or direct the patient back to the prescriber.'
Related Article: Pharmacists concerned they will see ‘very little’ of contract funding boost
A full list of SSPs can be found on the NHS Business Services Authority website.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.